Literature DB >> 21373235

Marketing, media, wishful thinking, and conflicts of interest: inflating the value of new medical technology.

Richard A Deyo.   

Abstract

Entities:  

Year:  2009        PMID： 21373235      PMCID： PMC3034436          DOI： 10.7812/TPP/08-087

Source DB:  PubMed          Journal:  Perm J        ISSN： 1552-5767


× No keyword cloud information.
  31 in total

1.  A national survey of provisions in clinical-trial agreements between medical schools and industry sponsors.

Authors:  Kevin A Schulman; Damon M Seils; Justin W Timbie; Jeremy Sugarman; Lauren A Dame; Kevin P Weinfurt; Daniel B Mark; Robert M Califf
Journal:  N Engl J Med       Date:  2002-10-24       Impact factor: 91.245

2.  Association between competing interests and authors' conclusions: epidemiological study of randomised clinical trials published in the BMJ.

Authors:  Lise L Kjaergard; Bodil Als-Nielsen
Journal:  BMJ       Date:  2002-08-03

3.  Impact of covert duplicate publication on meta-analysis: a case study.

Authors:  M R Tramèr; D J Reynolds; R A Moore; H J McQuay
Journal:  BMJ       Date:  1997-09-13

4.  Guest authorship and ghostwriting in publications related to rofecoxib: a case study of industry documents from rofecoxib litigation.

Authors:  Joseph S Ross; Kevin P Hill; David S Egilman; Harlan M Krumholz
Journal:  JAMA       Date:  2008-04-16       Impact factor: 56.272

5.  Newly approved does not always mean new and improved.

Authors:  Geoffrey M Anderson; David Juurlink; Allan S Detsky
Journal:  JAMA       Date:  2008-04-02       Impact factor: 56.272

Review 6.  Influences on the quality of published drug studies.

Authors:  L A Bero; D Rennie
Journal:  Int J Technol Assess Health Care       Date:  1996       Impact factor: 2.188

7.  Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

Authors: 
Journal:  JAMA       Date:  2002-12-18       Impact factor: 56.272

8.  Bioequivalence of generic and brand-name levothyroxine products in the treatment of hypothyroidism.

Authors:  B J Dong; W W Hauck; J G Gambertoglio; L Gee; J R White; J L Bubp; F S Greenspan
Journal:  JAMA       Date:  1997-04-16       Impact factor: 56.272

9.  Redundancy, disaggregation, and the integrity of medical research.

Authors:  P Huston; D Moher
Journal:  Lancet       Date:  1996-04-13       Impact factor: 79.321

10.  Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: nested case-control study.

Authors:  David J Graham; David Campen; Rita Hui; Michele Spence; Craig Cheetham; Gerald Levy; Stanford Shoor; Wayne A Ray
Journal:  Lancet       Date:  2005 Feb 5-11       Impact factor: 79.321
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.